Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trial

Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trial

Abstract SARS-CoV-2 and its different variants caused a “wave and wave” pandemic pattern. During the first wave we demonstrated that standardized Brazilian green propolis extract (EPP-AF®) reduces length of hospital stay in adult patients with COVID-19. Afterwards, we decided to evaluate the impact...

Full description

Bibliographic Details
Main Authors: Marcelo Augusto Duarte Silveira, Matheus de Alencar Menezes, Sergio Pinto de Souza, Erica Batista dos Santos Galvão, Andresa Aparecida Berretta, Juliana Caldas, Maurício Brito Teixeira, Marcel Miranda Dantas Gomes, Lucas Petri Damiani, Bruno Andrade Bahiense, Julia Barros Cabral, Cicero Wandson Luiz Macedo De Oliveira, Talita Rocha Mascarenhas, Priscila Carvalho Guedes Pinheiro, Milena Souza Alves, Rodrigo Morel Vieira de Melo, Flávia Mendes Leite, Carolina Kymie Vasques Nonaka, Bruno Solano de Freitas Souza, Nathália Ursoli Baptista, Flávio Teles, Suzete Farias da Guarda, Ana Verena Almeida Mendes, Rogério da Hora Passos
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-43764-w

Similar Items

Similar Items